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The vast majority of mature T cells are either of the CD4+8- or the CD4-8+
phenotype. The CD4cell surface glycoprotein is expressed primarily on the surface
of helper T cells, whose TCR recognize antigen on APCs in the context of class
II MHC molecules. TheCD8 molecule is primarily expressed on T cells, in partic-
ular CTL, whose TCR recognize antigen in the context ofclass I MHC molecules.
The TCR on helper T cells and CTL has been identified as a disulfide-linked ado
heterodimer with a molecular weight of 80,000-90,000 (reviewed in reference 1).
The binding ofCD4 and CD8 molecules to nonpolymorphic regions ofclass II and
class I MHC molecules, respectively, enhances the binding oftheTCR to itsligand
and may also contribute to signals leading to T cell activation (2, 3).
We have constructed TCR transgenic mice with the aim to study the selection
oftheTcellrepertoire. Tothis end, u andatransgenes obtained from anHYspecific,
H-21)6-restricted cytolytic CD4-8+ T cell clone were injected into fertilized eggs.
We have reported that in female ca/(3 transgenic mice a large proportion of T cells
is male specific and expresses both ce and (3 transgenes. In male mice we found that
cells with an abnormal CD4/CD8 phenotype accumulated in the periphery, with
the vast majority ofa//3 Tcells being CD4-8- and a minoritybeing CD4-8+ . The
latter expressed, however, low levels of CD8 accessory molecules. Due to the lack
ofan appropriateantibody we could not directly address the question as towhether
ornot thesecellsexpressedthe transgenicreceptor. Herewedescribe theuseofmAbs
that detect cells expressing both a anda transgenes. Using these antibodies we find
that in male H-2Db mice thevast majority ofperipheral T cells express both a and
a transgenes. Our studies indicate that despite the fact that precursorT cells, which
express a low density ofthe transgenic TCR, are largely deleted in the thymus of
male transgenic mice (4), the majority ofT cells spared by the deletion express a
high density of the transgenic TCR but a low density of CD8 molecules.
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H-2n mice expressing a and a TCR transgenes derived from the male-
specific B6.2.16 clone were constructed as previously described (5).
Normal Mice.
￿
C57BL/6, CBA/J, and DBA/2 mice were purchased from IFFACREDO,
St. Germain-sur-fArbresle, France. AKR/J and BALB.B mice were obtained from the an-
imal colony at the Basel Institute for Immunology.
T Cell Clones. The transgenic a/0-expressing clone B6.2.16 and the transgenic /3-expressing
clone 93.2.20 were established as previously described (6). The a-expressing clone 264.2.5.3
was established by stimulating lymph node cells from an a-transgenic mouse with X-irradiated
DBA/2 spleen cells in IL-2-containing medium. After 14 d the cells were washed and res-
timulated (106 responder cells and 10' X-irradiated stimulator cells) in IL-2-containing
medium. Cloning was carried out by limiting dilution in 96-well microtiter plates containing
106 X-irradiated DBA/2 spleen cells per well and optimal concentrations of IL-2. After 1-2
wk, growing colonies were transferred together with 10' X-irradiated DBA/2 spleen cells into
2 ml ofIL-2-containing medium in 24-well Costar (Cambridge, MA) plates. From then on,
restimulation was carried out at 7-14-d intervals with 106 cloned cells and 10' X-irradiated
DBA/2 spleen cells per 1 ml of IL-2-containing medium.
Surface Staining ofLymphocytes.
￿
Single cell suspensions were prepared from thymus, lymph
nodes (mesenteric, axillary, and inguinal), or spleen. The cells were washed once in RPMI
1640 and once in PBS with 5% FCS before staining. For staining the following mAbs were
used: FITC-labeled and biotinylated CD8 antibodies (anti-mouse Lyt-2, Becton Dickinson
& Co., Mountain View, CA), phycoerythrin (PE)-labeled CD4 antibody (anti-mouse L3T4,
Becton Dickinson & Co.), unconjugated F23.1 (7), T3.70 (see below), and CD3 (clone 145.2cll,
reference 8) mAbs. Optimal concentrations ofstaining reagents were predetermined and used
in the experiments described in this report. For single staining of cells, the cells were incubated
first with the unconjugated mAb for 20 min on ice, washed twice with PBS + 5 17o FCS, and
incubated for a further 20 min on ice with FITC-conjugated sheep (Fab')2 fragment
anti-mouse Ig (Silenus Laboratories, Melbourne, Australia). The cells were washed three
more times before being analyzed on the FACScan flow cytometer (Becton Dickinson & Co.)
5 x 103 cells were analyzed in each sample.
Double labeling of thymocytes with F23.1 and CD4 or CD8 mAbs was achieved by in-
cubating the cells first with unconjugated F23.1 followed by FITC-labeled sheep (Fab')2 frag-
ment anti-mouse Ig. To saturate free mouse Ig binding sites for the FITC-labeled antibody
the cells were incubated with whole mouse serum (2% vol/vol) for 20 min after the FITC
step. The cells were then stained directly with PE-labeled CD4 or with biotinylated CD8
followed by streptavidin PE (Becton Dickinson & Co.). A similar procedure was used to stain
the cells with T3.70 and CD4 or CD8 mAbs. Two-color fluorescence was analyzed using the
FACScan flow cytometer with a single Argon laser. 104 cells were analyzed in each sample.
Dead cells were excluded from analysis using a combination of low angle and sideways light
scatter. The results are presented as density plots. Where applicable, percentages were calcu-
lated using FACScan research software programs. Markers were set against negative controls
which involved cells that were incubated with PBS + 5% FCS and second stage-labeled re-
agents, i.e., FITC-labeled anti-mouse Ig or streptavidin PE, and analyzed in the same manner
as the double stained cells.
Production ofa mAb, T3.70 that Detects the Transgenic a chain.
￿
Five BALB.B (H-26) mice were
immunized with four intraperitoneal injections of 2 x 10' B6.2.16 cells given a week apart.
A week after the fourth injection the mice were tail bled and the sera were used to stain B6.2.16
(a/(3-expressing) and 93.2 .20 ((3-expressing) cells. One of the five immunized BALB.B mice
yielded an antiserum that gave a 5% differential in staining ofB6.2 .16 and 93.2 .20 cells. This
mouse was rested for 4 wk and given an intravenous injection of 2 x 10' B6.2.16 cells 3 d
before fusion with the HATsensitive, non-Ig-producing myeloma cell line, AG8.653 . A total
of 140 wells from this fusion contained growing hybridoma cells and supernatants from these
wells were used to stain B6.2.16 and 93.2 .20 cells. 20 supernatants gave good staining ofB6.2.16.
10 of these supernatants also stained 93.2.20 and were omitted from further analysis. The
remaining 10 supernatants were then used to stain thymocytes from B6 and female a/R trans-
genic H-2b Mice. Of these 10 supernatants only one stained the transgenic thymocytes inTEH ET AL.
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the manner shown in Fig. 3 and did not stain B6 thymocytes. The other nine supernatants
did not stain transgenic or normal thymocytes. The hybridoma cells producing this antibody
were subcloned at 0.3 cells/well. All subclones (20 of 20 tested) gave the same staining pattern
of female transgenic thymocytes as indicated in Fig. 3 . This mAb is referred to as T3 .70
and is of the IgGI subclass.
Immunoprecipitation of 7CR.
￿
B6.2 .16 and 93.2.20 cells were labeled with 1211 using the lac-
toperoxidase/glucose oxidase method. Cells (2-5 x 107) were washed three times with PBS
and suspended in 1 ml of PBS. 50 jl of lactoperoxidase (50 U/ml)/glucose oxidase (10 U/ml)
mixture was added followed by 1 mCi of Na 12'1 and 50 J,l of n-glucose (200 mM). The cells
were mixed and incubated for 30 min at room temperature. The cells were washed five times
in PBS/0.1% NaN3/5% FCS before lysing in lysing buffer containing 20 mM NaH2PO4 (pH
7.6), 150 mM NaCl, 2 mM EDTA, 8 mM iodoacetamide, 2% Triton X-100, 1 MM MgC12,
1 mM PMSF, 40 KIU/ml aprotinin, and 5 Rg/ml leupeptin.
The solid-phase immunoisolation technique (9) was used to immunoprecipitate TCRs.
The V-bottomed wells on an ELISA plate were coated with 100,ul of0.1 mg/ml affinity-purified
rabbit anti-mouse Ig at 4oC overnight. The wells were washed three times with PBS. 100
jAl of 20 Wg/ml of protein A-purified F23 .1 or T3.70 mAbs were added to each well and in-
cubated for 4 h at room temperature. The wells were washed three times with PBS and in-
cubated with 200 p.l of PBS + 5 % FCS for further 4 h at room temperature. The wells were
washed three times with PBS and 100 pl of 1211-labeled B6.2 .16 or 93 .2.20 cell lysates (equiva-
lent to 2 x 107 cells/ml) were added to each well. The wells were incubated at VC overnight.
The wells were then washed six times with PBS/Tween 20.
The bound proteins from each well were eluted by incubating with 100 j,1 of SDS sample
buffer for 30 min at room temperature. The eluted proteins were analyzed on a 10% poly-
acrylamide gel under nonreducing or reducing (with 2-ME) conditions. Autoradiography
was accomplished with Kodak X-Omat AR film.
Results
Production ofa mAb thatDetects the Transgenic a chain.
￿
The /3 transgene uses the V#8.2
gene segment, and its expression on T cells can be monitored by the F23 .1 mAb
(7), which detects all three members of the V08 gene family (10). It has been shown
that the (3 transgene prevents both functional and nonfunctional V(3 rearrangements
in the endogenous a chain loci but not D0JO rearrangements. Thus, T cells from
(3 as well as a//3 transgenic mice expressed almost exclusively the transgenic (3 chain
on their cell surface (4, 6). It has also been shown that in H-2b a/a transgenic mice,
rearrangement of endogenous a chain loci is also suppressed, although to a lesser
extent than that observed for (3 chain loci (5). To address more directly the question
of expression of the transgenic a or endogenous a genes on various T cell subsets,
we prepared a mAb that permits the detection of the transgenic a chain on T cells.
For this purpose we immunized BALB.B mice with the B6.2.16 clone from which
the a and a transgenes were isolated. An mAb, referred to as T3 .70, was obtained
(see Materials and Methods). The staining patterns of T3 .70 for the parental B6.2.16
T cell clone, the 93 .2 .20 T cell clone derived from a 0 transgenic mouse, and the
264.2.5.3 T cell clone derived from an a transgenic mouse are shown in Fig. 1. It
is clear that the B6.2 .16 (a//3-expressing) clone is stained equally well by the F23.1
and T3.70 mAbs. In contrast, the 93.2.20 (0-expressing) clone is stained only by
F23.1 and not at all by T3 .70. T3.70 also gave weak staining of the 264.2.5.3 (Cl-
expressing) clone. These experiments are compatible with the notion that T3.70 binds
either to an idiotypic determinant that is dependent on expression of both trans-
genic a and a chains or to a determinant on the a chain only. This would mean
that the 264.2 .5.3 clone expressses endogenous u chains in addition to the trans-798
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Preferential binding of the T3.70 mAb to T cells expressing transgenic a chains .
The 136.2.16 (a/0-expressing), 93 .2.20 (/3-expressing) and 264.2.5 .3 (a-expressing) T cell clones
were stainedwith F23.1,T3.70, orCD3 InAbs and analyzed asdescribed in MaterialsandMethods .
The x-axis indicates log fluorescence and the y-axis relative cell number in linear scale .
genica chain . Recent experiments in fact support the latter notion : After transfec-
tion of thea and ,(3 genes into cell lines that already express a different a/a hetero-
dimer we observed cells that stained -10 times better with the T3.70 than the F23.1
antibody. This suggests that the idiotype seen by the T3 .70 antibody does not de-
pend on the transgenic /3 chain .
mAbs to a/aTCR are expected to immunoprecipitate from detergent lysates of
appropriateT cells adisulfide-linked heterodimer of 80,000-90,000 molecularweight .
By using the solid-phase immunoisolation technique (9) we were able to immuno-
precipitate theTCRa//3 heterodimer from 136.2.16with both F23 .1 and T3.70mAbs
(Fig . 2) . On the other hand, the TCR from the 93 .2.20 (/3-expressing) clone was
precipititated only by F23.1 but not by T3.70 (Fig. 2) . These data confirmed that
T3.70 binds to the a/o heterodimer on 136.2.16 cells .
Expression oftheaand,8 Transgenes in Transgenic Thymocytes .
￿




F23.1 andT3.70mAbs . 136.2.16and 93.2.20 were
surface labeled with 1251. Detergent lysates of la-
beled cells were used for the isolation of theTCR
by the solid-phase immunoisolation technique
(see Materials and Methods). Proteins eluted
from wells to whichno mAb (A), the F23 .1 (B),
ortheT3.70 (C)mAbwas attached were analyzed
under reduced or nonreduced conditions on a









cytes from normal and a//3 transgenic H-2b mice by F23.1 and T3.70 are shown
in Fig. 3. As previously reported (4) and shown here for comparison, female trans-
genic thymocytes gave a high and a low level of staining by F23.1. A similarly high
and lowlevel of staining of female transgenic thymocytes by T3.70 is also observed.
Furthermore, it is clear that some female transgenic thymocytes were not stained
by T3.70 (11). In contrast to F23.1, which stained -10% of C57BL/6 thymocytes;
T3 .70 did not stain any thymocytes from C57BL/6 mice nordid it stain thymocytes
from CBA/J or AKR/J mice (data not shown). These observations suggest that the
T3 .70 idiotype is relatively uncommon.
The thymocytes in female transgenic H-2b mice that express low density of F23.1
and T3 .70 idiotypes correspond to immature CD4+8+ thymocytes that are progen-
itors of mature CD4+8- and CD4- 8+ T cells; in male ado transgenic mice, this
population is largelydeleted (4). As indicated in Fig. 3, most ofthe male thymocytes
that escaped deletion only expressed a high density of the F23.1 and T3.70 idio-
types. To further analyze the CD4/CD8 phenotype of thymocytes that expressed
this high leveloftransgenic ct and0 chains, male transgenic thymocytes were double
stained with combinations of CD4, CD8, F23.1, and T3 .70 mAbs. We know from
previous studies that female transgenic thymocytes, like normal C57BL/6 thymo-









Staining offemale andmale transgenic thymocytes by F23.1 and T3.70. Thymocytes
from a female or a male H-26a/Stransgenic mice and anormal C57BL/6mouse were stained
with F23.1 and T3.70 mAb and analyzed as described in Materials and Methods.800
￿
T CELL RECEPTOR/CD8 AND SELF-REACTIVE T CELL DELETION
principle difference from normal C57BL/6 thymocytes is in the increase in number
ofCD4-8+ T cells (5) . In contrast, male transgenic thymocytes do not segregate
into well-defined subsets on the basis of labeling with CD4 and CD8 antibodies .
The most distinctive features of the male transgenic thymus is the largeCD4- 8-
population and the lack of a well-defined CD4+ 8 ` population (4) .
Double staining of male thymocytes with CD4 and F23.1 or T3 .70 on the one
hand, andwithCD8 andF23.1 orT3.70 on theother, is shown in Fig. 4. It is evident
from such double staining that the most prominent population in the male trans-
genic thymus is the CD4-8- population (80% of male thymocytes) that expresses
high levels of the transgenic TCR. Double staining with CD4 and CD8 indicated
that in the male thymus the CD4+ 8+ population makes up ti8% of male thymo-
cytes and expresses low levels ofCD4 andCD8 (data not shown) . Fig . 4 shows that
most thymocytes expressing lowCD4 andCD8 levels also express high levels of the
transgenic TCR. Very few thymocytes howeverexpress high levels ofCD4 and high
levels of the transgenic TCR. In fact, a significant number of CD4+8- thymocytes
(4% of total) express no detectable levels of the transgenic a and ,(3 chains . They
presumably express endogenousa anda genes, which hasbeen shownto be possible
in cells that have deleted both transgenes (5). On the other hand, most of the CD8+
FIGURE 4 .
￿
Stainingofmale transgenic thymocytes by F23.1,T3.70,CD4andCD8 mAbs . Thymo-
cytes were double stained with F23.1 andCD4 orCD8and with T3.70 and CD4 or CD8 mAbs
and analyzed as described in Materials and Methods .U
FIGURE 5 .
￿
Staining of nylon wool nonadherent male transgenic spleen cells by F23.1, T3.70,
CD4, and CD8 mAbs . Nylon wool nonadherent spleen cells were prepared as previously de-
scribed (12) . Thenonadherent cells were double stained with F23.1 andCD4 orCD8 and with
T3.70 and CD4 or CD8 and analyzed as described in Materials and Methods .
Lymph node calls




Comparison oflymph node cells from female andmale a/S transgenic mice by staining
with Thy-1, F23.1, CD4, and CD8 antibodies .802
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thymocytes that expresshigh levels ofthe receptor express lower levels ofCD8 mole-
cules (N10-20% of that observed in female cells (see below) .
Expression oftheaand,Q Transgenes onMale TransgenicTCells.
￿
SplenicT cells stained
by the same method used to stain thymocytes are shown in Fig . 5 . The splenocytes
were enriched forT cells by passing over a nylon wool column . The nonadherent
cells were 66% Thy-1+ and 8% Ig+, with 26% of the spleen cells expressing nei-
ther Thy-1 nor Ig markers. Double staining with CD4 and CD8 indicates that
CD4- 8' T cells constitute the majorT cell population in the spleen (58% of Thy-
1' cells) ; 20% of Thy-1' were CD4'8 - and <2% of the T cells were CD4+8+ .
Double staining of splenicT cells with CD4 and F23 .1 or T3 .70 or with CD8 and
F23.1 or T3.70 showed that the most prominent T cell population was the CD8+
population that expresses high levels of both the a and a transgenic chains but low
FIGURE 7 .
￿
Staining ofCD4- 8- male transgenic lymph node cells with F23.1 or T3.70 mAbs.
Lymphnode cells from amale transgenic mouse were stained with PE-labeled CD4, FITC-labeled
CD8, and FITC-labeled anti-mouse Ig antibodies. The labeled cells were then separated from
the unlabeled cells using aFAGS IV (Becton Dickinson &Co.). The sortedCD4- 8- cells were
then stained with either the F23.1 or the T3.70 mAb and analyzed as described in Materials
and Methods .levels of CD8. Fig. 6 shows that amonglymph node cells the most prominent popu-
lation contains CD4- 8- T cells and that the CD4- 8' T cells in male mice express
lower CD8 levels when compared with T cells from female mice (Figs. 5 and 6).
Very few T cells were CD4+ 8- and transgenic TCR high. The majority of the
CD4' 8- cells (15% of Thy-1+ cells) expressed undetectable levels of both of the a
and a transgenes. We also deduced from this analysis that -18% of the Thy-1'
spleen cells were CD4- 8- and expressed high levels of transgenic a and R chains.
Lymph node cells from male transgenic mice contained -80% Thy-1+ cells, of
which 24% were CD4- 8', 5% were CD4+ 8- , and 71% were CD4- 8- . To directly
determine whether CD4- 8- T cells express the a and (3 tansgenic chains rather
than .y/S TCRs, these cells were enriched by staining with CD4, CD8, and anti-Ig
antibodies and sorting for unstained cells using the FAGS. As indicated in Fig. 7,
the sorted cells were phenotypically C134- 8- . All the CD4- 8- cells were Thy-1
(datanot shown) and expressedhigh levels of both a and/3 transgenic chains (Fig. 7).
CD4- 81°0 T Cellsfrom Male Mice Are Tolerant to HYAntigen.
￿
The proliferative re-
sponses of CD8+ T cells from female and male a/a transgenic mice induced by Con
A or H-2b male stimulator cells were compared. As shown in Fig. 8 both types of















Proliferation ofCD4- 8' lymph
node T cells from various male (y-axis) in re
A3
￿
sponse to stimulation by Con A and male
stimulator cells. Various numbers ofT cells
were cultured with 5 x 105 X-irradiated
spleen cells from female or male C57B1/6
mice. The cells showed no proliferation in the
presence offemale stimulatorcells (not shown)
but proliferated significantly in the presence
ofCon A or male stimulator cells. All cultures
contained IL-2 (5).804
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mice responded tomaleantigen(Fig. 8). Neither oftheTcells showed anysignificant
response when cultured with female stimulator cells (not shown).
Discussion
The analysis of T cell subset composition in male transgenic H-2b mice allows
the direct evaluation of the impact of the nominal antigen on the development of
T cells in these mice (4, and this report). The observations can be summarized as
follows: (a) In male transgenic mice CD4+8+ precursors expressing lowlevels ofthe
transgenic TCRhave been largely deleted inthe thymus; (b) themajor T cellpopu-
lation in the thymus is of the CD4-8- phenotype and expresses high levels of the
transgenic TCR; (c) in the periphery, the two major T cell subsets are CD4-8'°W
and CD4- 8- cells and both subsets express high levels ofthe transgenic TCR; (d)
the number of CD4+8- cells in the periphery is greatly reduced when compared
with normal ora/(3 transgenic female mice. Very few ofthese CD4+ 8- cells express
the transgenic TCR.
On the basis ofthese observations we conclude that the presence ofthe nominal
antigen in H-2b transgenic mice leads to deletion ofprecursor cells expressing the
self-reactive TCR. The deletion affects mostly CD4+8+ cells or their CD4-8+
precursors (13) and this is reflected in the reduced number of thymocytes and the
high proportion ofCD4-8- thymocytes expressing thetransgenic receptor. A reduc-
tionin thenumberofallthymocytesin TCR transgenic mice expressing a particular
TCR and the relevant class I MHC antigen simultanously was not observed by Sha
et al. (14). This is not in conflict with our results because in the mice described by
Sha et al. only a fraction ofthe thymocytes express the transgenic receptor. For the
same reason the authors do not observe a reduction in the number ofCD4+8- T
cells since they can be selected from CD4+8+ thymocytes expressing endogenous
receptor chains. In fact, the authors (14) cite their own unpublished data on trans-
genic mice with higher levels ofTCR expression confirming essentially the results
reported here and in a previous publication (4). One may wonder why CD4+8+
precursor cells expressing low levels of the transgenic receptor are deleted but
CD4-8" cells expressing high levels of the receptor can escape the deletion pro-
cess. One could argue that the precursors of the CD4- 8'°`" cells are initially
CD4+8'°"' TCR'°"'. The low CD8 expression allows them to escape deletion but this
phenotype can still be positively selected (11) to differentiate into CD4-8'°' TCRhigh
T cells. These cells, because oftheir low CD8 levels, cannot be activated by male
cells, i.e. they are harmless for the animal. The alternative possibility is that toler-
ance can not only be achieved by deletion of immature CD4+8+ T cells but can
also beachieved bydownregulation ofCDaccessorymolecules. At present wecannot
determine whether the CD4- 8'°', TCR high cells survive because of an inherent
CD8'°"' phenotype or whether their CD8 molecules are actively downregulated
when they get into contact with male cells. The latter mechanism would not neces-
sarily result in drastically reduced thymocyte numbers whereas a deletion, which
spares a minor population, would be reflected in smaller numbers of thymocytes.
Our future experiments are aimed at testing the stability ofthe CD4-8'°`" TCR high
phenotype by transferring these cells into female and male recipients.
The results shown here demonstrate that tolerance does not necessarily require
the elimination of all T cells expressing an autospecific TCR. Obviously the fewTEH ET AL.
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cells that escape thedeletion mechanism, becauseof reducedlevels ofaccessory mol-
ecules or even lack ofaccessorymolecules, canmigratefrom the thymus andexpand
enormously in the periphery such that the thymus contains only few cells of this
phenotype but the periphery contains almost normal numbers of Thy-1' cells. This
view of peripheral expansion of thymus migrants is supported by the finding that
oneoftenobserves rare phenotypes in theperipheryofmale but not femalecdo trans-
genic mice. We have previously notedperipheral T cells that haddeleted both trans-
genes and express endogenous ct/(3genes(5) and here we find that asignificant propor-
tion of CD4' 8- cells seem to lack both transgenes but express an endogenous
receptor. In summary, tolerance to T cells expressing an autospecific TCR in the
male transgenic mouse is achieved through deletion of CD4' 8+ precursor cells ex-
pressing low levels of this transgenic TCR and the lack of development of mature
Tcellsthat expresshigh levels of this autospecific TCR and normal levels of CD4/CD8
molecules.
Our experiments are compatible with recent experiments concerned with toler-
ance of CD4' 8- cells (13, 15). These authors used CD4 antibodies to interfere with
tolerance induction and concluded that also in their system the deletion occurred
at the level of CD4' 8' thymocytes. In addition, the authors provided evidence that
the accesory molecules played a crucial role in tolerance induction: CD4-8' cells
expressing the autospecific a/(3 receptor could be found in these animals without
any signs of autoimmunity (13, 15).
Summary
Transgenic mice that carryon alarge fraction oftheir Tcells anado Tcell receptor
that recognizes the male antigen in the context of H-2Db molecules were con-
structed. An mAb specific for the transgenic receptor was developed and used to
analyze T cell subsets in male transgenic H-2b mice. The vast majority of imma-
ture CD4' 8' T cells that express the transgenic TCR were deleted in the male
transgenic mouse. Nevertheless, the majority of T cells spared by this deletion pro-
cess expressed a high level of the transgenic TCR. These T cells, however, had an
abnormal CD4/CD8 phenotype in that they expressed either no CD8 molecules or
only low levels.
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